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Aim: The aim of our study was to analyse the association between the fasting triglyceride (TG) 
and cholesterol (TC) levels and all-cause/cardiovascular mortality. 
 
Methods: We have examined 3,143 males and 3,650 females, aged 58.3±7.1 years. 729 deaths 
(274 cardiovascular deaths) have been registered (11.8 years of follow-up). 
 
Results: The lowest total and cardiovascular mortality (P<0.01) were associated with TC 
between 5.15-6.18 mmol/L. For TC and LDL-cholesterol, the relationships exhibit the “U” 
shape curve. For TG values, both total and cardiovascular mortality are increasing through the 
categories 3.01-4.00 mmol/L (P<0.05) and over 4.00 mmol/L (P<0.005) in comparison with 
the reference group of 1.41-1.80 mmol/L. Age-sex adjusted all-cause mortality was higher in 
individuals with TG values 3.01-4.00 mmol/L (P=0.035) and over 4.00 mmol/L (P=0.002) 
when compared with a reference group. The results have been similar when cardiovascular 
mortality has been examined, however, results reached statistical significance only for the TG 
over 4.0 mmol/L (P=0.028). Associations did not significantly change after exclusion of cases 
within two years after examinations, or adjustment for statin treatment, age and sex. 
 
Conclusions: Our results confirmed that enhanced plasma levels of plasma triglycerides are 
dose dependently associated with increased risk of all-cause mortality, however, it seems that 
individuals with TG values 1.8-3.0 mmol/L are not in higher risk of death. The results do not 
support the assertion, that elevated levels of total and LDL-cholesterol levels are linearly 
associated with a higher total and cardiovascular mortality. 
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